Welldoc is Expanding – The Patent Data Can Tell Us Where

Welldoc is a healthcare company that develops solutions for managing chronic diseases. Its chronic care management platform uses AI to track and implement healthcare plans tailored to specific conditions such as diabetes, heart failure,…

Whoop 4.0 – Invisible Wearables, Various Sensors, Improved Batteries – What about patents?

Whoop is a wearable device company geared towards athletes. The company has been highlighted in a recent insight for its role in the Consumer Sleep Technology Patent Forecast®, as it continues to develop sleep technology. It also currently…

AI Meets Virtual Healthcare

Outpatient care is increasingly provided via telehealth consultations. According to a study published in the Journal of the American Informatics Association, virtual urgent care visits grew by 600% and nonurgent virtual visits grew by…

AI is the Future of Orthopaedic Surgery

Orthopaedic surgeries require substantial force to properly insert an implant for a patient. Some orthopaedic surgeries require a surgeon to hammer an implant to align in with a patient's autonomy. One problem with this is that surgeons…

Time For Your TV To Track Your Calories

It’s said that abs are made in the kitchen, but now it might be possible from your couch. This is great news for Americans, who on average spend over 4 hours a day watching TV!  Sony was issued a patent for monitoring the health condition…

Dexcom and the Race to Non-Invasive Glucose Monitoring

Dexcom leads glucose monitoring in the AI Biotech Patent Forecast® with 48 patent assets as shown in the radian above. So far, the company’s main focus has been making its continuous glucose monitoring (CGM) systems compatible with major…

Flow Acquires Halo Neuro and its 28 Patent Assets – Now What?

Neuromodulation is technology that alters nerve activity by delivering electrical or chemical signals directly to a target area. Flow Neuroscience uses such technology to treat depression, which is associated with lower neural activity in…

Google Restructures Its Health Division – Patent Data Will Predict The Next Steps

As Google restructures its health unit, patent activity will be key to predicting its future endeavors. This was previously shown when Patent Forecast® predicted Google’s acquisition of Fitbit in 2019. This $2.1B acquisition was closed as…

How Cognoa’s Use Of AI Is Transforming Diagnostic Procedure For Children

Cognoa is a pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with behavioral health conditions. The company announced June 2nd, 2021 that the FDA granted its De Novo classification…

Microsoft Takes A Nuanced Approach to AI Healthcare

Artificial intelligence has become an invaluable tool in neuroscience due to its ability to vastly improve our understanding of the human brain, and therefore make us better equipped to diagnose and treat neurological disorders. Emerging…

Is T-Mobile Developing a Wearable?

Have you ever looked at your phone and immediately felt your stress and blood pressure increase due to a phone call? What if you had a wearable device that is able to correlate your stress with a phone call and screen the call for…

Why Patent Assets Helped Secure $80 Million for Tesseract Health

Patent assets provide competitive advantage for a company, even when it is not the first entrant to a market. Retinal imaging and artificial intelligence is not a new concept (See (1) RetinAi,  (2) Diagnos, (3) PixelPlex, and (4) DeepMind…

Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees

Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest for promotion, it might have exaggerated a bit.  In early April 2021, Cala Health had 2 patent…

Capital One is Investing in AI Biotech? What’s in their wallet?

In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they belong? While 2 assets in 18 months may not seem substantial on the surface, the AI Biotech field is…

Sony is Exploring the AI/Biotech Diagnostics Sector. Ask us how we know.

When people think of Sony products, they usually think of audio, visual, and storage devices. That is because a majority of Sony's products fall into one of these categories. However, Sony's recent patent activity suggests that it may be…

Apex Neuro Inventions May Be Poised to Impact the Neuromodulation Field

Investment in patents always leads market activity.  So Apex Neuro's investments in key research and development implicate its positioning for market launch in the coming years. So far, Patent Forecast shows 5 patent assets from Apex Neuro…

Neurology Companies Take Note: A New Data Management Player has Entered the Field

On February 25th, a new competitor joined the increasingly crowded space in the Neurology Sector. Rune Labs, a San Francisco-based biotech startup had 4 applications published. Each of these documents teach a system or method related to…

The First Company to use Genomic Data for Fitness Recommendations. Should other Companies Take Note?

There is no doubt that improved technologies have greatly reduced the amount of time necessary to sequence human genomes. In the past, it would take weeks or even months to sequence a single person's genome. Modern technology has greatly…

You’ll get a kick out of this

Sufferers of Restless Leg Syndrome (RLS) will tell you that there is nothing worse than trying to fall asleep with restless legs. The disorder, which affects nearly 3 million people annually in the US, is characterized by a nearly…

Movano holds the missing key for‚”Apple?‚”Samsung?

This past week, Movano Inc. had its 3rd patent issued. The patent, U.S. Pat. No. 10,888,242, teaches a method and system of monitoring various health parameters from a small sensor embedded into a smartphone case. Notably, the sensor…

Patent Data as an Early Warning of New Competitors

Well-organized patent data can really make a difference for your company. One of the most powerful benefits of patent data is that it allows you to better understand your competitor landscape. Most established companies know who the big…

Boston Scientific Gains Slight Edge for 2020 Lead in AI-Neurology IP

With the issuance of US Pat. No. 10,842,997, Boston Scientific has gained a small lead in the AI Biotech: Neurology sector as the end of 2020 draws near. The ‘997 patent is the 13th patent granted to Boston Scientific in the Neurology…

Thought Beanie invests in mood detection. Apple, Facebook & Amazon ignores. Uh oh…

The idea of monitoring a wearers mood has been around for a long time (think back to the mood rings you had in middle school), but a quick look at the AI Biotech/Diagnostics: Neurology Sector seems to indicate that there is still a large…

Medtronic’s New Inventions Will Make Your Heart Skip a Beat … And They Know It

Ever since the string of now famous Life Alert® commercials began, the image of an elderly person alone and in need of medical assistance has been carved into the public conscience. Frequently, those with preexisting heart conditions are…

Using Neurostimulation to Replace Chemical Anti-Depressants

This past week, biotech-startup Inner Cosmos LLC had its first patent application publish (US Pat. Pub. No. 20200330749), and in doing so, joined the ever-growing neurostimulation market. The California-based startup is currently working…

Patent Forecast® gives you AI-driven, interactive data that identifies key innovators and first movers.

Includes interactive Patent Radian, real-time USPTO updates, and market insights.

TRY IT FREE FOR 7 DAYS